货号：GS40794
Visugromab (CTL-002) is an investigational human monoclonal antibody that specifically targets and neutralizes Growth Differentiation Factor 15 (GDF-15). It is being developed primarily for use in oncology, aimed at reversing GDF-15-mediated T-cell suppression within the tumor microenvironment, thereby potentially restoring anti-tumor immune responses, especially in combination with immune checkpoint inhibitors.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook，有助于交易顺利完成！
冉凯凯